DrugPatentWatch Database Preview
Investigational Drug Information for Pictilisib
Email this page to a colleague
What is the development status for investigational drug Pictilisib?
Pictilisib is an investigational drug.
There have been 6 clinical trials for Pictilisib.
The most recent clinical trial was a Phase 2 trial, which was initiated on January 20th 2012.
The most common disease conditions in clinical trials are Breast Neoplasms, Glioblastoma, and Lung Neoplasms. The leading clinical trial sponsors are Genentech, Inc., Roche Pharma AG, and Royal Marsden NHS Foundation Trust.
There are five hundred and eighty-two US patents protecting this investigational drug and six international patents.
Summary for Pictilisib
| US Patents | 582 |
| International Patents | 6,150 |
| US Patent Applications | 1,833 |
| WIPO Patent Applications | 1,262 |
| Japanese Patent Applications | 506 |
| Clinical Trial Progress | Phase 2 (2012-01-20) |
| Vendors | 87 |
Recent Clinical Trials for Pictilisib
| Title | Sponsor | Phase |
|---|---|---|
| PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclib | Institute of Cancer Research, United Kingdom | Phase 1 |
| PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclib | Pfizer | Phase 1 |
| PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclib | Roche Pharma AG | Phase 1 |
Clinical Trial Summary for Pictilisib
Top disease conditions for Pictilisib
Top clinical trial sponsors for Pictilisib
US Patents for Pictilisib
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Pictilisib | ⤷ Try it Free | Compounds and their methods of use | Agios Pharmaceuticals, Inc. (Cambridge, MA) | ⤷ Try it Free |
| Pictilisib | ⤷ Try it Free | Substituted thiohydantoin derivatives as androgen receptor antagonists | Janssen Pharmaceutica NV (Beerse, BE) | ⤷ Try it Free |
| Pictilisib | ⤷ Try it Free | In vitro production of foregut stem cells | Cambridge Enterprise Limited (GB) | ⤷ Try it Free |
| Pictilisib | ⤷ Try it Free | Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines | Signal Pharmaceuticals, LLC (San Diego, CA) | ⤷ Try it Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Pictilisib
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Pictilisib | Australia | AU2015231053 | 2034-03-21 | ⤷ Try it Free |
| Pictilisib | Brazil | BR112016021620 | 2034-03-21 | ⤷ Try it Free |
| Pictilisib | Canada | CA2943339 | 2034-03-21 | ⤷ Try it Free |
| Pictilisib | China | CN106231900 | 2034-03-21 | ⤷ Try it Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
